Pablo Legorreta, Royalty Pharma CEO (Patrick T. Fallon/Bloomberg via Getty Images)

Roy­al­ty Phar­ma tops its record-set­ting $3.3B deal with CF Foun­da­tion, bet­ting $575M more on Ver­tex's drugs

Roy­al­ty Phar­ma’s $3.3 bil­lion deal with the Cys­tic Fi­bro­sis Foun­da­tion to pur­chase roy­al­ties on Ver­tex’s CF fran­chise was its largest roy­al­ty deal ever. But that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.